The US Chamber of Commerce has requested that India be classified as a Priority Foreign Country, a tag given to the worst offenders when it comes to protecting intellectual property and one that could trigger trade sanctions.

The IT and BPO industry will lead the way and scout for acquisitions in Europe, according to Avendus Capital, the Mumbai-based investment bank.

Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent.

The Indian market may remain volatile until the elections but it would give an opportunity to build a strong portfolio. Shying away from Indian equities then will not be a good idea.

No doubt the growth of the Indian pharma industry will continue to be in double digits, but it is also becoming difficult for domestic companies to survive in the current scenario, writes WNS Global Services' Deepak Wadhwa.

The joint report, prepared by Keidanren (Japan Business Federation) focuses on building stronger business ties between Japan and India

Peter Lynch is a rock star for investors around the world. One reason for this is his extensive writings where he shares, in a simple manner, how he invests. Money Today tells you how you can benefit from his investing strategy.

Stocks of pharmaceutical companies had a stellar run in 2013. The trend is likely to continue. According to the India Brand Equity Foundation, the main drivers for the industry will be outsourcing and investments by MNCs, spread of health insurance and improved health-care facilities.

The move is significant because the Toansa facility supplies two-thirds of the company's APIs (active pharmaceutical ingredients) needs.

Billionaire philanthropist Bill Gates has showered rich praise on companies from emerging nations, including India, for donning the role of 'hidden vaccine heroes' and driving down their cost to about $1 per dose in the global fight to protect kids from deadly diseases.

Events of the fortnight that you may have missed. Featuring: Infosys third quarter results, SC on natural gas pricing dispute, Facebook's first acquisition in India and more.

Big investors are getting into home health care, using technology and the cloud, and trying to set benchmarks. Their success depends on getting the combination of service charges, delivery efficiency and market response right.

More people in India are now opting for integrative health-care. The growing popularity of traditional forms of medication indicates a move towards a natural philosophy of life with focus more on yoga, natural foods and chemical-free foods.

The Indian pharmaceutical industry faces a crucial new year. Until now, the local industry has largely followed a growth model that focused on launching cheap generic versions of branded innovator drugs made by global pharmaceutical companies.

The New Year offers great investment opportunities for retail investors as the country's economy looks to emerge from a prolonged lean phase. This is, therefore, time for investors to make smart decisions to reap the benefits of a reviving economy.

Apart from the two current favourites, IT and pharma, financial services, segments of automobile industry and companies associated with industrial capex will perform well in 2014, says Anand Rathi, Chairman, Anand Rathi Financial Services.

Thomas DeLong says a crisis can destroy an organisation if it does not respond appropriately. During a crisis or in a low growth environment, organisations fall apart, unless they have leaders with the courage to be transparent and set an example.

FIIs have increased their stake in select stocks. Money Today analayses data over four quarters to see which stocks FIIs have been buying and selling in the last one year to give a hint about where to invest in 2014.

In a nation where cricket is a religion, badminton is attracting more sport enthusiasts, equipment suppliers and business savvy sponsors thanks to players like Saina Nehwal, P.V. Sindhu, Jwala Gutta and Parupalli Kashyap regularly winning international tournaments.

The way Indian pharmaceutical companies develop drugs is a model that should be followed across the world, said Anita McGahan, Professor of Strategic Management at Rotman School of Management in University of Toronto.